BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5004482)

  • 1. [Stimulation of peripheral human lymphocytes in vitro with Zn 2+ in patients with lymphogranulomatosis and chronic lymphatic leukemia].
    Rühl H; Scholle H; Krichner H
    Acta Haematol; 1971; 46(6):326-37. PubMed ID: 5004482
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stimulation of blood lymphocytes through phytohemagglutinin in chronic lymphadenosis lymphosarcomatosis and lymphogranulomatosis].
    Scheurlen PG; Pappas A; Ludwig T
    Klin Wochenschr; 1968 May; 46(9):483-90. PubMed ID: 5695449
    [No Abstract]   [Full Text] [Related]  

  • 4. [The blood lymphocytes under the light- and electron microscope after stimulation with phytohemagglutinin. II. Phytohemagglutinin transformation of lymphocytes by Hodgkin's disease and chronic lymphatic leukemia].
    Pappas A; Orfanos C; Scheurlen PG
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 149(4):294-305. PubMed ID: 5772875
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of correlation of lymphocyte response to phytohemagglutinin with the clinical and immunologic status in chronic lymphocytic leukemia.
    Han T
    Cancer; 1973 Feb; 31(2):280-5. PubMed ID: 4120023
    [No Abstract]   [Full Text] [Related]  

  • 6. Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer.
    Sutherland RM; Inch WR; McCredie JA
    Cancer; 1971 Mar; 27(3):574-8. PubMed ID: 5279329
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the cellular immunocompetence in chronic lymphatic leukemia and malignant lymphoma patients as assessed by the local graft versus host reaction in rats.
    Shohat B; Joshua H; Ben-Bassat M
    J Reticuloendothel Soc; 1974 Nov; 16(5):276-81. PubMed ID: 4155447
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the surface membrane of lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.
    Mintz U; Sachs L
    Int J Cancer; 1975 Feb; 15(2):253-9. PubMed ID: 1126758
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro leukocyte thymidine uptake in chronic lymphocytic leukemia.
    Lopez-Sandoval R; Moayeri H; Sokal JE
    Cancer Res; 1974 Jan; 34(1):146-50. PubMed ID: 4809454
    [No Abstract]   [Full Text] [Related]  

  • 10. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. 3. Chronic lymphatic leukaemia.
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):69-77. PubMed ID: 4702206
    [No Abstract]   [Full Text] [Related]  

  • 11. The impaired responsiveness of chronic lymphatic leukemia lymphocytes to allogeneic lymphocytes.
    Smith MJ; Browne E; Slungaard A
    Blood; 1973 Apr; 41(4):505-9. PubMed ID: 4265958
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 13. Normal T cell population in chronic lymphocytic leukemia: analysis of phytohemagglutinin dose-response curves.
    Ziegler JB; Hansen PJ; Davies WA; Penny R
    J Reticuloendothel Soc; 1974 Nov; 16(5):269-75. PubMed ID: 4216631
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.
    Benezra D; Hochman A
    Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemic lymphocyte behaviour in mixed or PHA stimulated cultures.
    Macavei I; Halmoş S
    Rev Roum Med Intern; 1973; 10(4):315-20. PubMed ID: 4126519
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of peripheral blood lymphocytes from normal, hypogammaglobulinemic and chronic lymphocytic leukemic patients.
    Rodey GE; Davis T; Quie PG
    J Immunol; 1972 Jan; 108(1):178-82. PubMed ID: 4622005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
    Beck ID; Lemmel EM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphology of cell nucleoli, fluorescent microscopy findings and degree of blastic lymphocyte transformation in chronic lymphocytic leukemia, Hodgkin's disease and aplastic anemia].
    Judkiewicz L; Pluzańska A; Polkowska-Kulesza E; Zebrowski A; Musial W
    Acta Haematol Pol; 1971; 2(4):327-33. PubMed ID: 4122079
    [No Abstract]   [Full Text] [Related]  

  • 20. [T- and B-lymphocytes in lymphogranulomatosis].
    Il'in NV; Letskiĭ VB; Vinokurova NA
    Vopr Onkol; 1977; 23(6):9-15. PubMed ID: 303412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.